Variant report

Variant	nsv437832
Chromosome Location	chr19:43507069-43800961
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:3996)
CpG islands
(count:2013)
Chromatin interactive
region (count:6)
LncRNA
region (count:48)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:3996 , 50 per page) page: 1 2 3 4 5 6 7 ... 80

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr19:43779068-43779071	K562	blood:	n/a	n/a
2	ATF1	chr19:43733581-43733686	K562	blood:	n/a	n/a
3	ATF3	chr19:43686016-43686763	A549	lung:	n/a	n/a
4	BATF	chr19:43775309-43775522	GM12878	blood:	n/a	n/a
5	BATF	chr19:43552261-43552460	GM12878	blood:	n/a	chr19:43552319-43552330
6	BATF	chr19:43692397-43692675	GM12878	blood:	n/a	n/a
7	BATF	chr19:43711409-43711658	GM12878	blood:	n/a	n/a
8	BATF	chr19:43552186-43552537	GM12878	blood:	n/a	chr19:43552319-43552330
9	BATF	chr19:43738081-43738296	GM12878	blood:	n/a	chr19:43738185-43738196
10	BATF	chr19:43613006-43613315	GM12878	blood:	n/a	chr19:43613110-43613121
11	BATF	chr19:43692257-43692526	GM12878	blood:	n/a	n/a
12	BATF	chr19:43798559-43798850	GM12878	blood:	n/a	chr19:43798663-43798674
13	BATF	chr19:43591924-43592150	GM12878	blood:	n/a	n/a
14	BATF	chr19:43588401-43588710	GM12878	blood:	n/a	n/a
15	BHLHE40	chr19:43733601-43733620	K562	blood:	n/a	n/a
16	BHLHE40	chr19:43582147-43582203	K562	blood:	n/a	n/a
17	BHLHE40	chr19:43709323-43709343	K562	blood:	n/a	n/a
18	BRCA1	chr19:43624776-43624937	Hela-S3	cervix:	n/a	n/a
19	BRCA1	chr19:43525934-43526309	Hela-S3	cervix:	n/a	n/a
20	BRCA1	chr19:43769426-43769782	Hela-S3	cervix:	n/a	n/a
21	CBX3	chr19:43775276-43775644	K562	blood:	n/a	n/a
22	CBX3	chr19:43775261-43775711	HCT-116	colon:	n/a	n/a
23	CEBPB	chr19:43517268-43517468	HepG2	liver:	n/a	chr19:43517348-43517359
24	CEBPB	chr19:43705122-43705386	IMR90	lung:	n/a	n/a
25	CEBPB	chr19:43562867-43563067	Hela-S3	cervix:	n/a	n/a
26	CEBPB	chr19:43786125-43786327	Hela-S3	cervix:	n/a	n/a
27	CEBPB	chr19:43656366-43656852	IMR90	lung:	n/a	chr19:43656521-43656532
28	CEBPB	chr19:43656430-43656683	A549	lung:	n/a	chr19:43656521-43656532
29	CEBPB	chr19:43582058-43582378	Hela-S3	cervix:	n/a	n/a
30	CEBPB	chr19:43686010-43686301	A549	lung:	n/a	n/a
31	CEBPB	chr19:43510146-43510361	IMR90	lung:	n/a	chr19:43510191-43510202
32	CEBPB	chr19:43685962-43686735	A549	lung:	n/a	n/a
33	CEBPB	chr19:43656390-43656701	K562	blood:	n/a	chr19:43656521-43656532
34	CEBPB	chr19:43685985-43686627	IMR90	lung:	n/a	n/a
35	CEBPB	chr19:43582033-43582419	IMR90	lung:	n/a	n/a
36	CEBPB	chr19:43562943-43563108	MCF-7	breast:	n/a	n/a
37	CEBPB	chr19:43705598-43705699	IMR90	lung:	n/a	n/a
38	CEBPB	chr19:43564423-43564649	IMR90	lung:	n/a	n/a
39	CEBPB	chr19:43656448-43656689	HepG2	liver:	n/a	chr19:43656521-43656532
40	CEBPB	chr19:43564424-43564703	Hela-S3	cervix:	n/a	n/a
41	CEBPB	chr19:43768999-43769727	IMR90	lung:	n/a	n/a
42	CEBPB	chr19:43618826-43619087	IMR90	lung:	n/a	n/a
43	CEBPB	chr19:43517258-43517378	A549	lung:	n/a	chr19:43517348-43517359
44	CEBPB	chr19:43516550-43516678	K562	blood:	n/a	n/a
45	CEBPB	chr19:43510075-43510341	Hela-S3	cervix:	n/a	chr19:43510191-43510202
46	CEBPB	chr19:43686079-43686251	A549	lung:	n/a	n/a
47	CEBPB	chr19:43656349-43656822	Hela-S3	cervix:	n/a	chr19:43656521-43656532
48	CEBPB	chr19:43588559-43588762	IMR90	lung:	n/a	n/a
49	CEBPB	chr19:43709791-43709942	Hela-S3	cervix:	n/a	n/a
50	CEBPB	chr19:43728619-43728662	Hela-S3	cervix:	n/a	n/a

(count:2013 , 50 per page) page: 1 2 3 4 5 6 7 ... 41

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:43711249-43711299	HPAEpiC	pulmonary alveolar:	n/a
2	chr19:43530536-43530586	Hepatocyte	liver:	n/a
3	chr19:43711064-43711114	NHBE	bronchial:	n/a
4	chr19:43709832-43709882	NH-A	brain:	n/a
5	chr19:43697480-43697530	AG09319	gingival:	n/a
6	chr19:43691930-43691980	HCM	heart:	n/a
7	chr19:43710277-43710327	HCF	heart:	n/a
8	chr19:43531821-43531871	HEK293	kidney:	embryo
9	chr19:43588025-43588075	U87	brain:	n/a
10	chr19:43709360-43709410	ovcar-3	ovarian:	n/a
11	chr19:43673501-43673551	Hepatocyte	liver:	n/a
12	chr19:43691930-43691980	NT2-D1	testis:	n/a
13	chr19:43514144-43514194	HRE	kidney:	n/a
14	chr19:43691930-43691980	PrEC	prostate:	n/a
15	chr19:43683698-43683748	Jurkat	blood:	n/a
16	chr19:43683698-43683748	IMR90	lung:	fetal
17	chr19:43709360-43709410	HCM	heart:	n/a
18	chr19:43588055-43588105	ovcar-3	ovarian:	n/a
19	chr19:43531770-43531820	AG04449	skin:	fetal
20	chr19:43769725-43769775	GM19239	blood:	n/a
21	chr19:43691930-43691980	HIPEpiC	eye:	n/a
22	chr19:43683698-43683748	NHBE	bronchial:	n/a
23	chr19:43588025-43588075	HCM	heart:	n/a
24	chr19:43569592-43569642	HEK293	kidney:	embryo
25	chr19:43587500-43587550	K562	blood:	n/a
26	chr19:43690622-43690672	NHBE	bronchial:	n/a
27	chr19:43569592-43569642	T-47D	breast:	n/a
28	chr19:43691878-43691928	ECC-1	luminal epithelium:	n/a
29	chr19:43588025-43588075	Hepatocyte	liver:	n/a
30	chr19:43683698-43683748	HUVEC	blood vessel:	n/a
31	chr19:43711064-43711114	GM12892	blood:	n/a
32	chr19:43691930-43691980	ovcar-3	ovarian:	n/a
33	chr19:43569592-43569642	HRCEpiC	kidney:	n/a
34	chr19:43774982-43775032	HRCEpiC	kidney:	n/a
35	chr19:43587500-43587550	NHBE	bronchial:	n/a
36	chr19:43774820-43774870	HNPCEpiC	eye:	n/a
37	chr19:43528994-43529044	HEK293	kidney:	embryo
38	chr19:43528994-43529044	A549	lung:	n/a
39	chr19:43588069-43588119	RPTEC	kidney:	n/a
40	chr19:43691930-43691980	SK-N-SH	brain:	n/a
41	chr19:43531770-43531820	HCM	heart:	n/a
42	chr19:43709832-43709882	ovcar-3	ovarian:	n/a
43	chr19:43774820-43774870	T-47D	breast:	n/a
44	chr19:43531770-43531820	SKMC	muscle:	n/a
45	chr19:43683698-43683748	SKMC	muscle:	n/a
46	chr19:43673501-43673551	SAEC	small airway:	n/a
47	chr19:43690996-43691046	HMEC	breast:	n/a
48	chr19:43773649-43773699	HPAEpiC	pulmonary alveolar:	n/a
49	chr19:43709654-43709704	LNCaP	prostate:	n/a
50	chr19:43709654-43709704	SKMC	muscle:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:43523469..43524084-chr19:43531918..43532440,2	MCF-7	breast:
2	chr19:43678340..43681333-chr19:43698109..43700078,2	MCF-7	breast:
3	chr19:43265768..43266290-chr19:43769932..43770473,2	MCF-7	breast:
4	chr19:43608137..43608719-chr19:43820621..43821519,2	MCF-7	breast:
5	chr19:43523469..43524084-chr19:43531918..43532440,2	MCF-7	breast:
6	chr19:43531581..43532101-chr2:1136088..1136613,2	MCF-7	breast:

(count:48 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PSG4-3	chr19:43674207-43674717	NONHSAT066586
2	lnc-PSG9-2	chr19:43737376-43737446	NONHSAT066591
3	lnc-CD177-1	chr19:43657665-43657763	ENSG00000227606.1
4	lnc-PSG9-2	chr19:43724140-43724394	NONHSAT066591
5	lnc-PSG9-2	chr19:43728324-43728464	NONHSAT066591
6	lnc-PSG11-1	chr19:43545168-43545400	NONHSAT066579
7	lnc-PSG5-1	chr19:43699147-43699301	NONHSAT066589
8	lnc-PSG1-1	chr19:43570669-43570753	NONHSAT066570
9	lnc-PSG2-2	chr19:43575923-43576106	NONHSAT066580
10	lnc-CD177-1	chr19:43665002-43665014	ENSG00000227606.1
11	lnc-PSG4-3	chr19:43671924-43672287	NONHSAT066585
12	lnc-PSG5-1	chr19:43696890-43697540	NONHSAT066588
13	lnc-PSG9-2	chr19:43762354-43762608	NONHSAT066592
14	lnc-PSG5-1	chr19:43698492-43699038	NONHSAT066588
15	lnc-CD177-1	chr19:43658863-43659311	ENSG00000227606.1
16	lnc-PSG5-1	chr19:43698107-43698746	NONHSAT066589
17	lnc-PSG9-2	chr19:43752160-43752275	NONHSAT066591
18	lnc-PSG9-2	chr19:43715943-43716627	NONHSAT066591
19	lnc-PSG4-1	chr19:43707241-43708403	NONHSAT066590
20	lnc-PSG2-4	chr19:43521383-43521753	NONHSAT066578
21	lnc-PSG9-2	chr19:43727043-43727110	NONHSAT066591
22	lnc-PSG2-2	chr19:43587104-43587197	NONHSAT066580
23	lnc-PSG11-1	chr19:43544526-43544780	NONHSAT066579
24	lnc-CD177-1	chr19:43659324-43659477	ENSG00000227606.1
25	lnc-PSG9-2	chr19:43763009-43764898	NONHSAT066592
26	lnc-PSG4-2	chr19:43684499-43684748	NONHSAT066587
27	lnc-PSG2-3	chr19:43600608-43600855	NONHSAT066582
28	lnc-PSG9-2	chr19:43724140-43724394	NONHSAT066593
29	lnc-CD177-1	chr19:43657431-43657763	ENSG00000227606.1
30	lnc-PSG9-2	chr19:43719405-43719531	NONHSAT066591
31	lnc-PSG2-5	chr19:43514422-43514579	NONHSAT066577
32	lnc-PSG2-4	chr19:43522922-43523199	NONHSAT066578
33	lnc-PSG9-2	chr19:43724783-43725023	NONHSAT066593
34	lnc-PSG2-5	chr19:43514110-43514858	NONHSAT066576
35	lnc-PSG2-5	chr19:43519268-43519426	NONHSAT066577
36	lnc-PSG2-2	chr19:43576503-43576781	NONHSAT066580
37	lnc-PSG4-3	chr19:43674207-43674723	NONHSAT066585
38	lnc-PSG9-2	chr19:43715943-43716627	NONHSAT066592
39	lnc-PSG2-1	chr19:43585939-43586423	NONHSAT066581
40	lnc-PSG2-1	chr19:43586658-43586820	NONHSAT066581
41	lnc-PSG4-2	chr19:43688934-43689087	NONHSAT066587
42	lnc-PSG2-3	chr19:43601248-43601512	NONHSAT066582
43	lnc-PSG9-2	chr19:43734076-43734177	NONHSAT066591
44	lnc-PSG4-3	chr19:43672274-43672355	NONHSAT066586
45	lnc-PSG11-1	chr19:43540021-43540112	NONHSAT066579
46	lnc-PSG4-1	chr19:43710321-43711451	NONHSAT066590
47	lnc-PSG9-2	chr19:43752643-43752798	NONHSAT066591
48	lnc-PSG2-5	chr19:43511982-43512194	NONHSAT066576

No data

Variant related genes	Relation type
PSG4	TF binding region
CEACAMP9	TF binding region
CEACAMP8	TF binding region
CEACAMP11	TF binding region
PSG2	TF binding region
ENSG00000227606	TF binding region
PSG5	TF binding region
PSG11	TF binding region
CEACAMP10	TF binding region
PSG9	TF binding region
PSG4	CpG island
CEACAMP9	CpG island
CEACAMP8	CpG island
CEACAMP11	CpG island
PSG2	CpG island
ENSG00000227606	CpG island
PSG5	CpG island
PSG11	CpG island
CEACAMP10	CpG island
PSG9	CpG island
ENSG00000243137	chromatin interactions

Extended variants
information (count: 15122 )
Associated
traits (count: 77 )

Variant overlapped rSNPs/rCNVs (count:15122 , 50 per page) page: 1 2 3 4 5 6 7 ... 303

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1860455	chr19:43507069-43507070	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs561273926	chr19:43507095-43507096	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs151275957	chr19:43507111-43507112	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs529939519	chr19:43507150-43507151	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs73555786	chr19:43507155-43507156	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs563674396	chr19:43507164-43507165	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs532507245	chr19:43507167-43507168	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs545422497	chr19:43507177-43507178	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs116431438	chr19:43507211-43507212	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs575464125	chr19:43507214-43507215	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs529325413	chr19:43507222-43507223	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs542837640	chr19:43507228-43507229	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs561013476	chr19:43507247-43507248	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs566009544	chr19:43507258-43507259	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs528711860	chr19:43507284-43507285	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs528574176	chr19:43507335-43507336	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs2354834	chr19:43507357-43507358	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs57008979	chr19:43507358-43507359	Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs369671889	chr19:43507359-43507360	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs397744490	chr19:43507368-43507369	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs140873545	chr19:43507415-43507416	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs557193111	chr19:43507431-43507432	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs569327892	chr19:43507466-43507467	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs142356526	chr19:43507482-43507483	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs397696344	chr19:43507492-43507493	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs3855672	chr19:43507507-43507508	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs558258950	chr19:43507512-43507513	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs150849217	chr19:43507547-43507548	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs139279612	chr19:43507568-43507569	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs149978452	chr19:43507573-43507574	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs187648039	chr19:43507575-43507576	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs2354833	chr19:43507580-43507581	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs145130923	chr19:43507581-43507582	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs373778797	chr19:43507592-43507593	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs4029157	chr19:43507598-43507599	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs113685071	chr19:43507619-43507620	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs532570310	chr19:43507628-43507629	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs370041666	chr19:43507629-43507630	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs2354832	chr19:43507633-43507634	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs546196760	chr19:43507637-43507638	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs2354831	chr19:43507640-43507641	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs2354830	chr19:43507651-43507652	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs528566952	chr19:43507656-43507657	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs2354829	chr19:43507659-43507660	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs551419269	chr19:43507677-43507678	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs2354828	chr19:43507691-43507692	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs141127212	chr19:43507718-43507719	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs35877162	chr19:43507737-43507738	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs2354827	chr19:43507739-43507740	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs568570852	chr19:43507768-43507769	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:77)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Astrocytoma	22246337	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21509527	CNVD
Cancer	20164920	CNVD
Ependymoma	20639864	CNVD
Multiple myeloma	16616336	CNVD
Ovarian cancer	20800559	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Spondylocostal dysostosis	21085971	CNVD
Nicotine metabolism	21956041	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Glioblastoma multiforme	17002787	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	16750200	CNVD
Colorectal cancer	20459617	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Ovarian cancer	21240255	CNVD
early-passage human iPS cells	21368824	CNVD
Primary Severe Spermatogenic Failure	20378930	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Melanoma	20877625	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:845 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:43506400-43507400	Enhancers	Fetal Muscle Leg	muscle
2	chr19:43506400-43508600	Enhancers	NHEK	skin
3	chr19:43506400-43508800	Enhancers	HMEC	breast
4	chr19:43506400-43510400	Enhancers	HSMMtube	muscle
5	chr19:43506600-43507200	Enhancers	A549	lung
6	chr19:43506600-43507600	Enhancers	Placenta	Placenta
7	chr19:43506600-43508800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
8	chr19:43506800-43508000	Enhancers	Breast Myoepithelial Primary Cells	Breast
9	chr19:43507000-43507800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr19:43507000-43508000	Enhancers	Hela-S3	cervix
11	chr19:43507200-43508000	Flanking Active TSS	A549	lung
12	chr19:43507200-43510400	Enhancers	NHDF-Ad	bronchial
13	chr19:43507400-43508400	Weak transcription	Fetal Muscle Leg	muscle
14	chr19:43507600-43508000	Enhancers	iPS-20b Cell Line	embryonic stem cell
15	chr19:43507600-43508000	Weak transcription	Placenta	Placenta
16	chr19:43507600-43508800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
17	chr19:43507800-43508200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
18	chr19:43508000-43508800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
19	chr19:43508000-43508800	Enhancers	A549	lung
20	chr19:43508000-43509200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
21	chr19:43508000-43509200	Weak transcription	Hela-S3	cervix
22	chr19:43508000-43511200	Enhancers	Placenta	Placenta
23	chr19:43508200-43508800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
24	chr19:43508200-43508800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr19:43508200-43508800	Enhancers	Skeletal Muscle Female	skeletal muscle
26	chr19:43508400-43508800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr19:43508400-43508800	Enhancers	Fetal Muscle Leg	muscle
28	chr19:43508400-43508800	Enhancers	Skeletal Muscle Male	skeletal muscle
29	chr19:43508400-43509000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
30	chr19:43508600-43509000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
31	chr19:43508800-43509200	Active TSS	Skeletal Muscle Male	skeletal muscle
32	chr19:43508800-43509600	Enhancers	iPS-20b Cell Line	embryonic stem cell
33	chr19:43509000-43509200	Enhancers	HSMM	muscle
34	chr19:43509200-43509400	Enhancers	Breast Myoepithelial Primary Cells	Breast
35	chr19:43509200-43510200	Enhancers	Skeletal Muscle Male	skeletal muscle
36	chr19:43509400-43509600	Enhancers	Hela-S3	cervix
37	chr19:43510200-43514800	Weak transcription	Skeletal Muscle Male	skeletal muscle
38	chr19:43511200-43518400	Weak transcription	Placenta	Placenta
39	chr19:43514800-43515600	Enhancers	Skeletal Muscle Male	skeletal muscle
40	chr19:43518400-43520000	Enhancers	Placenta	Placenta
41	chr19:43519600-43519800	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
42	chr19:43520000-43523200	Weak transcription	Placenta	Placenta
43	chr19:43520200-43520400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr19:43520800-43521000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
45	chr19:43521000-43525400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
46	chr19:43522600-43526000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr19:43523200-43523800	Enhancers	Placenta	Placenta
48	chr19:43523800-43524200	Weak transcription	Placenta	Placenta
49	chr19:43524200-43524400	Enhancers	Placenta	Placenta
50	chr19:43524400-43525000	Weak transcription	Placenta	Placenta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links